Is a complete NSE/AARTIDRUGS research report available?

Question

Accepted Answer

No complete published report is available for nse/AARTIDRUGS (NSE/AARTIDRUGS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	36.9B
Revenue (ttm)	25.7B
Net income (ttm)	1.9B
EPS (ttm)	₹21.4
P/E (trailing)	18.9x
P/E (forward)	18.0x
Dividend	₹2.00 (0.49%)
Volume	82,962

Metric	Value
Country	India
Country code	IN
Employees	1,284
Employees Change	220%
Employees Change Percent	20.68
Enterprise value	INR 42.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	38.88
Industry PE Fwd	33.68
Isin	INE767A01016
Last refreshed	2026-07-27
Market cap	INR 36.9B
Price	INR 408
Price currency	INR
Rev Per Employee	19,979,049.84x
Sector	Healthcare
Sector PE	45.49
Sector PE Fwd	37.04
Sic	2836
Symbol	nse/AARTIDRUGS
Website	https://www.aartidrugs.co.in

Metric	Value
Earnings Yield	5.28%
EV Earnings	21.78x
EV/EBIT	17.36x
EV/EBITDA	13.63x
EV/FCF	52.93x
EV/Sales	1.66x
FCF yield	2.17%
Forward P/E	18.04x
P/B ratio	2.38x
P/E ratio	18.95x
P/S ratio	1.44x
PE Ratio10 Y	20.1x
PE Ratio3 Y	23.74x
PE Ratio5 Y	23.51x

Metric	Value
EBIT Margin	9.54%
EBITDA Margin	12.15%
FCF margin	3.13%
Gross margin	36.9%
Gross Profit	INR 9.5B
Gross Profit Growth	14.65%
Gross Profit Growth Q	22.36%
Gross Profit Growth3 Y	5.51%
Gross Profit Growth5 Y	2.84%
Net Income	INR 1.9B
Net Income Growth	15.91%
Net Income Growth Q	-12.2%
Net Income Growth Years	1%
Net Income Growth3 Y	5.43%
Net Income Growth5 Y	-7.02%
Pretax Margin	8.22%
Profit Margin	7.6%
Profit Per Employee	INR 1.5M
Profitable Quarters	INR 56
Profitable Years	21
ROA	5.67
Roa5y	6.85
ROCE	12.92
ROE	13.36
Roe5y	15.17
ROIC	10.98
Roic5y	11.73

Metric	Value
Cagr10y	12.43%
Cagr15y	24.84%
Cagr1y	-23.29%
Cagr20y	21.95%
Cagr3y	-6.9%
Cagr5y	-10.42%
Div CAGR10	1.71%
Div CAGR3	25.99%
Div CAGR5	-7.79%
EPS Growth	15.93
EPS Growth Q	-12.03
EPS Growth Years	1
EPS Growth3 Y	5.95
EPS Growth5 Y	-6.62
FCF Growth	18.98%
FCF Growth5 Y	3.75%
OCF Growth	3.66%
OCF Growth10 Y	6.64%
OCF Growth3 Y	23.89%
OCF Growth5 Y	10.35%
Revenue Growth	7.47x
Revenue Growth Q	6.43x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.89x
Revenue Growth5 Y	3.55x

NSE/AARTIDRUGS (NSE/AARTIDRUGS)

Coverage state: Market snapshot only — no published research

Generate the first NSE/AARTIDRUGS analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/AARTIDRUGS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/AARTIDRUGS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSE/AARTIDRUGS

Frequently asked questions

Metric	Value
Asset Turnover	INR 0.95
Assets	INR 28.2B
Cash	INR 242.8M
Current Assets	INR 14.7B
Current Liabilities	INR 9.2B
Debt	INR 5.8B
Debt EBITDA	INR 1.85
Debt Equity	INR 0.37
Debt FCF	INR 7.19
Equity	INR 15.5B
Interest Coverage	7.26
Liabilities	INR 12.7B
Long Term Assets	INR 13.5B
Long Term Liabilities	INR 3.4B
Net Cash	INR -5.5B
Net Cash By Market Cap	INR -14.96
Net Debt EBITDA	INR 1.77
Net Debt Equity	INR 0.36
Net Debt FCF	INR 6.89
Tangible Book Value	INR 15.3B
Tangible Book Value Per Share	INR 168
WACC	6.09

Metric	Value
Current ratio	1.59
Inventory Turnover	3.36
Net Working Capital	INR 8.4B
Quick ratio	0.93
Working Capital	INR 5.5B
Working Capital Turnover	INR 4.9

Metric	Value
Buyback Yield	0.02%
Dividend Growth	100%
Dividend Growth Years	0%
Dividend per share	INR 2
Dividend Years	5
Dividend Yield	0.49%
Ex Div Date	2026-02-09
Last Dividend	INR 2
Payout Frequency	Annual
Payout Ratio	9.32%

Metric	Value
10Y total return	222.78%
1Y total return	-23.27%
200-day SMA	400.1
3Y total return	-19.31%
50-day SMA	385.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-42.3%
All Time High	1,027
All Time High Change	-60.27%
All Time High Date	2020-10-08
All Time Low	3.95
All Time Low Change	10,229.11%
All Time Low Date	2009-02-20
ATR	13.78
Beta	0.35
Ch YTD	-0.89
High	410
High52	551.8
High52 Date	2025-07-25
High52ch	-26.05%
Low	401
Low52	319
Low52 Date	2026-03-30
Low52ch	27.92%
Ma50ch	5.88%
Price vs 200-day SMA	1.98%
RSI	54.55
RSI Monthly	47.67
RSI Weekly	54.07
Sharpe ratio	-0.72x
Sortino ratio	-0.86
Total Return	0.51%
Tr YTD	-0.35
Tr15y	2,687.92%
Tr1m	8.71%
Tr1w	-3.39%
Tr3m	9.69%

Metric	Value
Operating Income	INR 2.4B
Operating Income Growth	5.77
Operating Income Growth Q	22.76
Operating Income Growth3 Y	-1.41
Operating Income Growth5 Y	-8.82
Operating margin	9.54

Metric	Value
Float	35,372,091%
Net Borrowing	-269,800,000
Shares Insiders	47.31%
Shares Institutions	17.99%
Shares Qo Q	-0.05%
Shares Yo Y	-0.02%

Metric	Value
Adjusted FCF	INR 802.2M
Average Volume	231,876.1x
Bv Per Share	169.8
CAPEX	INR -1.7B
Ch10y	214.3
Ch15y	2,213.2
Ch1m	8.71
Ch1w	-3.39
Ch1y	-23.68
Ch20y	3,582
Ch3m	9.69
Ch3y	-20.09
Ch5y	-43.11
Ch6m	10.26
Change	-0.49%
Change From Open	-0.24
Close	410
Days Gap	-0.24
Depreciation Amortization	669,700,000
Dollar Volume	33,848,496
Earnings Date	2026-07-31
EBIT	INR 2.4B
EBITDA	INR 3.1B
EPS	INR 21.36
F Score	6
FCF	INR 802.2M
FCF EV Yield	1.89x
Financing CF	-774,400,000
Fiscal Year End	March
Founded	1,984
Graham Number	287.95805
Graham Upside	-29.42
Income Tax	INR 159.7M
Investing CF	-1,734,100,000
Is Primary Listing	0
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2020-09-30
Last Split Type	Forward
Lynch Fair Value	INR 108
Lynch Upside	-73.61
Ma150	377.5
Ma150ch	8.09%
Ma20	399.1
Ma20ch	2.22%
Net CF	26,900,000
Next Earnings Date	2026-07-31
Open	409
P FCF Ratio	46.04
P OCF Ratio	14.57
Payment Date	2026-03-05
Position In Range	77.78
Ppne	12,837,800,000
Price Date	2026-07-24
Price EBITDA	INR 11.85
Ptbv Ratio	2.41
Relative Volume	0.36x
Revenue	25,653,100,000x
Tax By Revenue	0.62x
Tax Rate	7.57%
Tr20y	5,193.88%
Tr6m	10.85%
Volume	82,962